Details of the Drug Reposition

General Information of This Drug (ID: DM04HNB)

Drug Name
Anti-CD19 CAR-T   DM04HNB
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
B-cell chronic lymphocytic leukaemia DISNHN2M 2A82.00 Phase 1 [1]
Acute lymphoblastic leukaemia DIS87TGM 2A85 Phase 1 [1]
Haematopoietic/lymphoid cancer DISNCK1H 2B33.5 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03110640) Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma